MACROGENICS INC. - COMMON STOCK

MacroGenics to Participate in Upcoming Investor Conference

02 12月 2024 15:30:00 条件 Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

06 11月 2024 15:30:00 条件 Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

05 11月 2024 15:01:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces Leadership Transition

30 10月 2024 06:30:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

29 10月 2024 15:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

24 9月 2024 08:46:10 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

23 9月 2024 09:42:43 条件 NetDania Notify

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

15 9月 2024 02:00:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

08 9月 2024 18:10:00 条件 Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

06 8月 2024 15:01:41 条件 Nasdaq GlobeNewswire

MacroGenics Provides Vobramitamab Duocarmazine Update

30 7月 2024 15:10:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte

30 7月 2024 15:01:00 条件 Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conference

11 6月 2024 06:45:00 条件 Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

13 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

10 5月 2024 09:01:03 条件 NetDania Notify

MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data

09 5月 2024 15:01:13 条件 Nasdaq GlobeNewswire

MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call

03 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire

MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures

03 4月 2024 15:30:00 条件 Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and 2023 Financial Results

07 3月 2024 15:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: MACROGENICS INC. - COMMON STOCK

06 3月 2024 09:28:25 条件 NetDania Notify